PTP Accounts Production v24.2.0.383 04890752 Board of Directors 1.1.23 31.12.23 31.12.23 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh048907522022-12-31048907522023-12-31048907522023-01-012023-12-31048907522021-12-31048907522022-01-012022-12-31048907522022-12-3104890752ns15:EnglandWales2023-01-012023-12-3104890752ns14:USDollar2023-01-012023-12-3104890752ns10:Director12023-01-012023-12-3104890752ns10:PrivateLimitedCompanyLtd2023-01-012023-12-3104890752ns10:SmallEntities2023-01-012023-12-3104890752ns10:AuditExempt-NoAccountantsReport2023-01-012023-12-3104890752ns10:SmallCompaniesRegimeForDirectorsReport2023-01-012023-12-3104890752ns10:SmallCompaniesRegimeForAccounts2023-01-012023-12-3104890752ns10:FullAccounts2023-01-012023-12-310489075212023-01-012023-12-3104890752ns10:Director22023-01-012023-12-3104890752ns10:CompanySecretary12023-01-012023-12-3104890752ns10:RegisteredOffice2023-01-012023-12-3104890752ns5:CurrentFinancialInstruments2023-12-3104890752ns5:CurrentFinancialInstruments2022-12-3104890752ns5:ShareCapital2023-12-3104890752ns5:ShareCapital2022-12-3104890752ns5:RetainedEarningsAccumulatedLosses2023-12-3104890752ns5:RetainedEarningsAccumulatedLosses2022-12-3104890752ns5:IntangibleAssetsOtherThanGoodwill2023-01-012023-12-3104890752ns5:IntangibleAssetsOtherThanGoodwill2023-12-3104890752ns5:WithinOneYearns5:CurrentFinancialInstruments2023-12-3104890752ns5:WithinOneYearns5:CurrentFinancialInstruments2022-12-3104890752ns5:Non-currentFinancialInstrumentsns5:AfterOneYear2023-12-3104890752ns5:Non-currentFinancialInstrumentsns5:AfterOneYear2022-12-31
REGISTERED NUMBER: 04890752 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 December 2023

for

Beryl Med. Limited

Beryl Med. Limited (Registered number: 04890752)






Contents of the Financial Statements
for the Year Ended 31 December 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Beryl Med. Limited

Company Information
for the Year Ended 31 December 2023







DIRECTORS: K G Brodaczewski
H M Brodaczewska





SECRETARY: FTI (Secretariat) Ltd





REGISTERED OFFICE: 2nd Floor
19 Margaret Street
London
W1W 8RR





REGISTERED NUMBER: 04890752 (England and Wales)






Beryl Med. Limited (Registered number: 04890752)

Balance Sheet
31 December 2023

31.12.23 31.12.22
Notes $    $    $    $   
FIXED ASSETS
Intangible assets 4 51,620 -

CURRENT ASSETS
Inventories 1,337,014 246,841
Debtors 5 1,991,322 2,016,519
Cash at bank 345,763 282,520
3,674,099 2,545,880
CREDITORS
Amounts falling due within one year 6 1,838,959 899,250
NET CURRENT ASSETS 1,835,140 1,646,630
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,886,760

1,646,630

CAPITAL AND RESERVES
Called up share capital 1,762 1,762
Retained earnings 1,884,998 1,644,868
1,886,760 1,646,630

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Beryl Med. Limited (Registered number: 04890752)

Balance Sheet - continued
31 December 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 17 March 2025 and were signed on its behalf by:





K G Brodaczewski - Director


Beryl Med. Limited (Registered number: 04890752)

Notes to the Financial Statements
for the Year Ended 31 December 2023

1. STATUTORY INFORMATION

Beryl Med. Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the US Dollar ($).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Revenue is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are
measured at cost less any accumulated amortisation and any accumulated impairment losses.

Development costs are being amortised evenly over their estimated useful life of 10 years.

Stocks
Inventories are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expenses that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company's liability for the current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.


Beryl Med. Limited (Registered number: 04890752)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2023

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2022 - 4 ) .

4. INTANGIBLE FIXED ASSETS
Other
intangible
assets
$   
COST
Additions 57,356
At 31 December 2023 57,356
AMORTISATION
Charge for year 5,736
At 31 December 2023 5,736
NET BOOK VALUE
At 31 December 2023 51,620

Beryl Med. Limited (Registered number: 04890752)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2023

5. DEBTORS
31.12.23 31.12.22
$    $   
Amounts falling due within one year:
Trade debtors 1,751,014 1,789,353
Other debtors 933 249
1,751,947 1,789,602

Amounts falling due after more than one year:
Other debtors 239,375 226,917

Aggregate amounts 1,991,322 2,016,519

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.23 31.12.22
$    $   
Trade creditors 1,494,023 465,080
Taxation and social security 231,092 371,465
Other creditors 113,844 62,705
1,838,959 899,250

7. ULTIMATE CONTROLLING PARTY

The controlling parties are K G BRODACZEWSKI and H M BRODACZEWSKA,company directors.